ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In fact, using a retrovirus-induced murine model of CML, Mumprecht and collaborators have shown that BCR–ABL-expressing DCs do not efficiently induce specific CTL immune response.22, 23, 24